U.S. federal trademark · Serial No. 75593719 · Reg. No. 2516118
House mark for pharmaceuticals used in the treatment of diseases in humans and in animals, namely, pharmaceutical preparations for use as an antidote to ethylene glycol and methanol poisoning, pharmaceutical preparations for use as a preparatory regime in connection with bone marrow transplants, pharmaceutical preparations for use as a treatment for acute and chronic radiation proctitis, pharmaceutical preparations for use as a treatment for homocystinuria, pharmaceutical preparations for use in the treatment and/or prevention of selected liver conditions, pharmaceutical preparations for use in the treatment of gastrointestinal and metabolic disorders, pharmaceutical preparations for use in the treatment of narcolepsy, and artificial cerebrospinal fluid
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.